Global Induced Pluripotent Stem Cell (iPSC) Market
Healthcare Services

Induced Pluripotent Stem Cell (iPSC) Market Growth and Trends: Key Insights into Market Opportunities for 2025-2034

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers Contributing to the Growth and Expansion of the Induced Pluripotent Stem Cell (iPSC) Market?

The surge in the instances of chronic ailments is a significant contributor to the expansion of the induced pluripotent stem cell market. Therapies using Induced pluripotent stem cells can treat chronic diseases like heart disease, cancer, stroke, and diabetes. These pluripotent stem cells, derived from a child or adult tissues, are genetically altered to replicate the behavior of embryonic stem cells. A report by the Partnership to Fight Chronic Disorder (PFCD) suggested that 45% of the American population, i.e., out of 133 million citizens, suffered from a minimum of one chronic disease. Furthermore, the report noted that chronic diseases were accountable for seven out of ten deaths in the USA, approximately 1.7 million, which could be managed with induced pluripotent stem cell therapy. Consequently, the ascending cases of chronic illnesses are propelling the demand for the induced pluripotent stem cell treatment market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2515&type=smp

#How Does the ProjectedInduced Pluripotent Stem Cell (iPSC) Market Growth Compare Over the Forecast Period?

The market for induced pluripotent stem cells (iPSC) has seen a quick expansion in its size in the past few years. The market is projected to escalate from $3.3 billion in 2024 to $3.67 billion in 2025, showcasing a compound annual growth rate (CAGR) of 11.3%. This significant growth in the historical period is a result of factors such as an increase in healthcare spending, augmented funding, growing knowledge about the medicinal benefits of stem cell products, utilization of induced pluripotent stem cell (iPSC) in drug discovery, a surge in demand for personalized medication, and the economic efficiencies of using iPSC in drug discovery.

In the upcoming years, the induced pluripotent stem cell (iPSC) market is projected to experience substantial expansion. Anticipated to have a compound annual growth rate (CAGR) of 9.6%, the market is predicted to reach $5.29 billion by 2029. This increase in market size can be traced back to several factors including the rising frequency of chronic and genetic diseases, advancements in genomic projects, progress in the development of IPSC-derived disease models, governmental initiatives, and a swift advancement in technology. Key trends projected for the future encompass the cultivation of pluripotent stem cells for Parkinson’s disease (PD), strategic alliances and partnerships, progression in the development of induced pluripotent stem cell IPSC-derived nk cells and IPSC for cell therapy, investment in research and development of regenerative medicine, and the creation of IPSC expansion medium, personalized IPSC, and pluripotent stem cells for type I diabetes.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2515

What New Market Trends Are Reshaping theInduced Pluripotent Stem Cell (iPSC) Market and Its Opportunities?

Firms within the Induced Pluripotent stem cell market are seeking strategic partnerships and collaborations as a way to penetrate new areas and broaden their range of products. One example is the January 2022 strategic partnership between Bristol Myers Squibb and Century Therapeutics, which was aimed at creating IPSC-derived allogenic cell therapies to combat acute myeloid leukemia and multiple myeloma. Moreover, in May 2022, Evotec and Sernova publicized a strategic alliance to develop IPSC-based beta cell replacement therapy for the management of type 1 and type 2 diabetes.

Who Are the Leading Market Players Fueling Growth in the Induced Pluripotent Stem Cell (iPSC) Market Trend?

Major companies operating in the induced pluripotent stem cell (iPSC) market include FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc), Thermo Fisher Scientific, Inc, Takara Bio, Inc, Lonza Group AG, Astellas Pharma Inc, ViaCyte, Inc, Ncardia, REPROCELL USA, Inc, Japan Tissue Engineering Co., Ltd, Merck KGaA, Cynata Therapeutics Limited, Dainippon Sumitomo Pharma, Shenzhen Bioscience, Shanghai Cell Therapy Group, Car-T Bio, JW therapeutics, Fosun Kite Biotechnology, Shanghai UniCar Therapy, Takaria Bio, SEED Biosciences SA, Cellerix, CellGenix, NsGene, TiGenix, Renuron Group, Smart Cells, Genenta Science, Biocad Rf, MSD, Pfizer, Roche, Pharmasyntez, Selvita, Mabion, Pure Biologics, OncoArendi Therapeutics, Proteon Pharmaceuticals, GlaxoSmithKline, Parexel, Bayer, Fate Therapeutics, Athersys, BrainStorm Cell Therapeutics, Cellular Biomedicine Group, Pluristem Therapeutics, Gamida Cell, VistaGen Therapeutics, Caladrius Biosciences, BioCanRx, CellCAN, CCRM, C3i, BioCells Argentina, Stem Cells, Royan Stem Cell Technology Co., Next BioSciences, CryoSave, BioHeart

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

How is the Global Induced Pluripotent Stem Cell (iPSC) Market Segemented?

The induced pluripotent stem cell (iPSC) market covered in this report is segmented –

1) By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types

2) By Application: Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy

3) By End-User: Hospitals, Research Laboratories

Subsegments:

1) By Hepatocytes: iPSC-Derived Liver Cells For Drug Toxicity Testing, Disease Modeling And Regenerative Therapies

2) By Fibroblasts: iPSC-Derived Skin Cells For Wound Healing And Tissue Repair, Fibroblast-Based Disease Research

3) By Keratinocytes: iPSC-Derived Skin Cells For Dermatological Research, Skin Regeneration Therapies

4) By Amniotic Cells: iPSC-Derived Cells For Prenatal Research, Amniotic Fluid-Based Regenerative Applications

5) By Other Derived Cell Types: Neurons For Neurological Disease Modeling, Cardiomyocytes For Heart Disease Studies, Endothelial Cells For Vascular Research

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=2515&type=smp

Which Geographics are Influencing the Growth of the Induced Pluripotent Stem Cell (iPSC) Market?

North America was the largest region in the induced pluripotent stem cell (IPSC) market in 2024. Western Europe was the second largest region in the global induced pluripotent stem cell (IPSC) market share. The regions covered in the induced pluripotent stem cell (IPSC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Global Induced Pluripotent Stem Cell (iPSC) Market 2025, By The Business Research Company:

Spectator Sports Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/spectator-sports-global-market-report

Participatory Sports Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/participatory-sports-global-market-report

Sports And Arts Promoters Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/sports-and-arts-promoters-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: